Skip to main content
. 2023 Jun 21;14:1198171. doi: 10.3389/fgene.2023.1198171

TABLE 1.

Age of onset and Wilcoxon Rank Sums test results for number of nonsense/frameshift variant analysis. (A) Sample size, median, and quartile age of onset information for each clinical manifestation for different numbers of nonsense/frameshift variants. (B) Wilcoxon Rank Sums test P- values and Bonferonni adjusted p-values for pairwise comparisons of nonsense/frameshift variant numbers. NSFS0: zero nonsense/frameshift variants. NSFS1: one nonsense/frameshift variant. NSFS2: two nonsense/frameshift variants.

Manifestation Number of NSFS variants Sample size (n) Median Lower quartile Upper quartile
A
Diabetes Mellitus NSFS0 109 8 5 11
Diabetes Mellitus NSFS1 87 7 4.35 9
Diabetes Mellitus NSFS2 129 5 4 6.8
Optic Atrophy NSFS0 97 11 8 19
Optic Atrophy NSFS1 87 12 9 16
Optic Atrophy NSFS2 123 10 7.45 12
Diabetes Insipidus NSFS0 46 14 10 18.0825
Diabetes Insipidus NSFS1 38 12 10 15.75
Diabetes Insipidus NSFS2 65 12 10 15
Hearing Loss NSFS0 59 12 8 17.15
Hearing Loss NSFS1 48 14 9 18
Hearing Loss NSFS2 88 14 10 19.25
Manifestation Comparison p-value Adjusted p-value
B
Diabetes Mellitus NSFS2-NSFS0 2.14E-09 2.57E-08
Diabetes Mellitus NSFS1-NSFS0 5.63E-02 6.76E-01
Diabetes Mellitus NSFS2-NSFS1 5.07E-05 6.09E-04
Optic Atrophy NSFS2-NSFS0 4.06E-03 4.87E-02
Optic Atrophy NSFS1-NSFS0 9.43E-01 1.00E+00
Optic Atrophy NSFS2-NSFS1 6.42E-04 7.71E-03
Diabetes Insipidus NSFS2-NSFS0 1.34E-01 1.00E+00
Diabetes Insipidus NSFS1-NSFS0 1.45E-01 1.00E+00
Diabetes Insipidus NSFS2-NSFS1 8.30E-01 1.00E+00
Hearing Loss NSFS2-NSFS0 2.71E-01 1.00E+00
Hearing Loss NSFS1-NSFS0 5.48E-01 1.00E+00
Hearing Loss NSFS2-NSFS1 5.40E-01 1.00E+00